MediLink Therapeutics Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 190

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $70M

  • Investors
  • 9

MediLink Therapeutics General Information

Description

Developer of antibody-drug conjugates (ADC) based in China. The company focuses on providing patients with ADC therapeutics that combat cancer while sparing healthy cells, keeping patients healthy while under treatment.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room A1-401
  • No. 412, Bio-Industrial Park
  • Suzhou, Jiangsu
  • China
+86 0512
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Room A1-401
  • No. 412, Bio-Industrial Park
  • Suzhou, Jiangsu
  • China
+86 0512

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MediLink Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series B) 01-Mar-2022 $70M Completed Clinical Trials - Phase 2
3. Early Stage VC 20-Feb-2022 Completed Pre-Clinical Trials
2. Early Stage VC (Series A2) 05-Mar-2021 $41M $41M Completed Pre-Clinical Trials
1. Early Stage VC (Series A1) 13-Dec-2020 Completed Pre-Clinical Trials
To view MediLink Therapeutics’s complete valuation and funding history, request access »

MediLink Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of antibody-drug conjugates (ADC) based in China. The company focuses on providing patients with ADC therapeut
Drug Discovery
Suzhou, China
190 As of 2024

Oxford, United Kingdom
 

Cleveland, OH
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

MediLink Therapeutics Competitors (9)

One of MediLink Therapeutics’s 9 competitors is Oxford Biotherapeutics, a Private Equity-Backed company based in Oxford, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Oxford Biotherapeutics Private Equity-Backed Oxford, United Kingdom
Abeona Therapeutics Corporation Cleveland, OH
CytomX Therapeutics Formerly VC-backed South San Francisco, CA
Ironwood Pharmaceuticals Formerly VC-backed Boston, MA
ADC Therapeutics Formerly VC-backed Epalinges, Switzerland
You’re viewing 5 of 9 competitors. Get the full list »

MediLink Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MediLink Therapeutics Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Highlight Capital Venture Capital Minority
Legend Capital Venture Capital Minority
LYFE Capital PE/Buyout Minority
Xiamen C&D Corporation Corporation Minority
FirstLight Capital (Beijing) PE/Buyout Minority
You’re viewing 5 of 9 investors. Get the full list »

MediLink Therapeutics Investments (1)

MediLink Therapeutics’s most recent deal was a Corporate Asset Purchase with SinoMab Bioscience (Property and Manufacturing Facility in Suzhou, China) for . The deal was made on 06-Jul-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
SinoMab Bioscience (Property and Manufacturing Facility in Suzhou, China) 06-Jul-2026 Corporate Asset Purchase
To view MediLink Therapeutics’s complete investments history, request access »

MediLink Therapeutics FAQs

  • When was MediLink Therapeutics founded?

    MediLink Therapeutics was founded in 2020.

  • Where is MediLink Therapeutics headquartered?

    MediLink Therapeutics is headquartered in Suzhou, China.

  • What is the size of MediLink Therapeutics?

    MediLink Therapeutics has 190 total employees.

  • What industry is MediLink Therapeutics in?

    MediLink Therapeutics’s primary industry is Drug Discovery.

  • Is MediLink Therapeutics a private or public company?

    MediLink Therapeutics is a Private company.

  • What is the current valuation of MediLink Therapeutics?

    The current valuation of MediLink Therapeutics is .

  • What is MediLink Therapeutics’s current revenue?

    The current revenue for MediLink Therapeutics is .

  • How much funding has MediLink Therapeutics raised over time?

    MediLink Therapeutics has raised $111M.

  • Who are MediLink Therapeutics’s investors?

    Highlight Capital, Legend Capital, LYFE Capital, Xiamen C&D Corporation, and FirstLight Capital (Beijing) are 5 of 9 investors who have invested in MediLink Therapeutics.

  • Who are MediLink Therapeutics’s competitors?

    Oxford Biotherapeutics, Abeona Therapeutics, CytomX Therapeutics, Ironwood Pharmaceuticals, and ADC Therapeutics are some of the 9 competitors of MediLink Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process